MapLight Therapeutics: Funding, Investors & Team (Sep 2026)
The purpose of MapLight Therapeutics is to create and advance treatments for brain disorders through their specialized platform. This platform utilizes a combination of single-cell transcriptomics and optogenetics to pinpoint new targets for drug development and ultimately create successful therapies for brain disorders.
MapLight Therapeutics has raised $50.0M across 1 funding round on record, the most recent an undisclosed round of $50.0M announced in Jul 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MapLight Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2023.
MapLight Therapeutics Funding Rounds
MapLight Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
MapLight Therapeutics Funding Compared to Other Biotechnology Startups
MapLight Therapeutics' latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MapLight Therapeutics in Biotechnology and Palo Alto
Companies Similar to MapLight Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
MapLight Therapeutics Funding FAQs
What does MapLight Therapeutics do?
The purpose of MapLight Therapeutics is to create and advance treatments for brain disorders through their specialized platform. This platform utilizes a combination of single-cell transcriptomics and optogenetics to pinpoint new targets for drug development and ultimately create successful therapies for brain disorders.
How much funding has MapLight Therapeutics raised?
MapLight Therapeutics has raised $50.0M across 1 round on record. The most recent is an undisclosed round of $50.0M announced in Jul 2023.
When did MapLight Therapeutics last raise funding?
MapLight Therapeutics' most recent funding round on record is an undisclosed round of $50.0M, announced in Jul 2023.
Who founded MapLight Therapeutics?
FundedIQ lists Mark Douglas (Founder) at MapLight Therapeutics.
Where is MapLight Therapeutics headquartered?
MapLight Therapeutics is based in Palo Alto, California, United States.
How many employees does MapLight Therapeutics have?
MapLight Therapeutics is in the 51-100 employee band.
How does MapLight Therapeutics' funding compare to other Biotechnology startups?
MapLight Therapeutics' latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's MapLight Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MapLight Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.